Taipei Exchange - Delayed Quote TWD

Sea Mild Biotechnology Co., Ltd. (7516.TWO)

Compare
9.20 -0.34 (-3.56%)
At close: November 15 at 2:59 PM GMT+8
Loading Chart for 7516.TWO
DELL
  • Previous Close 9.54
  • Open 9.54
  • Bid 9.17 x --
  • Ask 9.44 x --
  • Day's Range 9.11 - 9.54
  • 52 Week Range 8.20 - 12.70
  • Volume 34,675
  • Avg. Volume 49,895
  • Market Cap (intraday) 177.642M
  • Beta (5Y Monthly) -0.83
  • PE Ratio (TTM) 9.11
  • EPS (TTM) 1.01
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. Sea Mild Biotechnology Co., Ltd. is headquartered in Taoyuan City, Taiwan.

www.seamild.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7516.TWO

View More

Performance Overview: 7516.TWO

Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

7516.TWO
20.00%
TSEC CAPITALIZATION WEIGHTED ST
26.84%

1-Year Return

7516.TWO
1.77%
TSEC CAPITALIZATION WEIGHTED ST
34.45%

3-Year Return

7516.TWO
12.61%
TSEC CAPITALIZATION WEIGHTED ST
29.82%

5-Year Return

7516.TWO
52.79%
TSEC CAPITALIZATION WEIGHTED ST
98.62%

Compare To: 7516.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7516.TWO

View More

Valuation Measures

Annual
As of 11/15/2024
  • Market Cap

    177.64M

  • Enterprise Value

    188.73M

  • Trailing P/E

    9.11

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.66

  • Price/Book (mrq)

    2.06

  • Enterprise Value/Revenue

    0.70

  • Enterprise Value/EBITDA

    5.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.23%

  • Return on Assets (ttm)

    3.42%

  • Return on Equity (ttm)

    25.45%

  • Revenue (ttm)

    269.5M

  • Net Income Avi to Common (ttm)

    19.48M

  • Diluted EPS (ttm)

    1.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.42M

  • Total Debt/Equity (mrq)

    78.28%

  • Levered Free Cash Flow (ttm)

    2.51M

Research Analysis: 7516.TWO

View More

Company Insights: 7516.TWO

Research Reports: 7516.TWO

View More